Decreased intracellular zinc in human tumorigenic prostate epithelial cells: a possible role in prostate cancer progression
about
hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glandsThe clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dotsZinc and zinc transporters in prostate carcinogenesisZinc transporters in prostate cancer.Marginal zinc deficiency increases oxidative DNA damage in the prostate after chronic exercise.Dietary zinc deficiency effects dorso-lateral and ventral prostate of Wistar rats: histological, biochemical and trace element study.Zinc transporter expression profiles in the rat prostate following alterations in dietary zincA di-leucine sorting signal in ZIP1 (SLC39A1) mediates endocytosis of the protein.Docetaxel-mediated apoptosis in myeloid progenitor TF-1 cells is mitigated by zinc: potential implication for prostate cancer therapyEnzymatically active prostate-specific antigen promotes growth of human prostate cancers.Peptide-based, two-fluorophore, ratiometric probe for quantifying mobile zinc in biological solutionsAssessing prostate cancer growth with citrate measured by intact tissue proton magnetic resonance spectroscopy.Reversal of epigenetic silencing of AP-2alpha results in increased zinc uptake in DU-145 and LNCaP prostate cancer cells.Zinc as an anti-tumor agent in prostate cancer and in other cancers.Overexpression of the zinc uptake transporter hZIP1 inhibits nuclear factor-kappaB and reduces the malignant potential of prostate cancer cells in vitro and in vivo.Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL-6 and IL-8 in prostate cancer cells via NF-kappaB-dependent pathwayZinc intake from supplements and diet and prostate cancer.Reaction-based fluorescent sensor for investigating mobile Zn2+ in mitochondria of healthy versus cancerous prostate cells.Zinc and prostatic cancerZinc transporters are differentially expressed in human non-small cell lung cancer.The SLC39 family of zinc transporters.Decreased zinc and downregulation of ZIP3 zinc uptake transporter in the development of pancreatic adenocarcinomaAcute changes in cellular zinc alters zinc uptake rates prior to zinc transporter gene expression in Jurkat cells.The ZnR/GPR39 interacts with the CaSR to enhance signaling in prostate and salivary epithelia.PIAS1-modulated Smad2/4 complex activation is involved in zinc-induced cancer cell apoptosis.Glucose Metabolism in the Progression of Prostate Cancer.hZIP1 zinc transporter down-regulation in prostate cancer involves the overexpression of ras responsive element binding protein-1 (RREB-1).The miR-183 family cluster alters zinc homeostasis in benign prostate cells, organoids and prostate cancer xenografts.Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma.Evidence that Human Prostate Cancer is a ZIP1-Deficient Malignancy that could be Effectively Treated with a Zinc Ionophore (Clioquinol) Approach.Resveratrol-zinc combination for prostate cancer management.Zinc ion dyshomeostasis increases resistance of prostate cancer cells to oxidative stress via upregulation of HIF1α.Zinc Metallochaperones as Mutant p53 Reactivators: A New Paradigm in Cancer Therapeutics.
P2860
Q21093281-EEB240DB-0859-4DDC-A09D-94126187E568Q21093286-1F62C5DE-8521-423A-BFDD-D7AFDE76946CQ27010040-DDB0DA10-267F-42FB-83FF-BBBA0CEC64BDQ33715474-8FE7BF02-2E0D-4CDC-9CC7-32DF872D544FQ33875007-35F88654-28F5-4B8E-AF6B-1B07629D944AQ34041525-FC04FA31-F0F1-4E7E-8FB7-27C837856792Q34122236-DB3E3FD6-1A86-4BEA-88C7-3DAF16F71EADQ34652028-E658A3CF-A286-4752-8288-BF6381D0BD46Q35019472-28FF72C2-4955-436B-8476-E83B53EF13D8Q35048230-D96D9E7B-387E-4DCD-A8F7-5F12DA2825D6Q35108091-D251BA57-5DD2-4702-8F8C-3D969405E758Q35141481-C0451B07-8CF0-4757-B01C-18230AA86A35Q35562908-5A0F8211-779A-4209-BB8B-C61FD4650159Q36776709-288BB066-C883-4FC5-BD9C-38ABA089BB65Q36983959-FA3BEFD2-9210-4D36-8A9F-7A932AFD8726Q36984078-32C90643-034A-4300-9DC4-F78D180F8F9DQ37148783-5DBE0418-2603-445B-93BA-BC27FF46E8BBQ37474839-689F5131-A33B-4F78-AC50-A551CE7C67DAQ37580689-51A806A3-2E1B-438F-A621-79886A898654Q37687099-98015B27-CBDF-4491-A8D0-31E3DCD1AA3DQ38090794-2BC510BF-E59D-420C-9D17-BD91E8654B96Q38439880-592F2B0A-0BAF-4F74-9900-E980281F1C40Q38831420-01B95206-1C60-4351-8CCF-97ACCF4001C7Q39058706-6BC35227-A72D-4580-92F6-CF0AE2E383F9Q39093908-F34567F5-4A84-4522-84E5-342F78F9894EQ39167169-1AD790A6-C2B2-4F7C-97E1-B534833814C0Q39584306-1E583918-EE9D-4250-82F7-412901059C22Q41331870-EB13E17C-41A5-4E38-BD63-4BABB01F5D57Q42041007-D3E9705D-7280-47BF-BFB9-9AF93A5D8D7BQ42430413-AAEB9D94-FDE9-4842-A1E3-FCA7F75ACD70Q42750085-5711BB67-3436-45D1-B879-8C1E1213951DQ50321810-05E96FED-F763-46F2-A658-97B8779E2927Q55471290-749F5A49-4798-44B1-BD17-F5063AA9390A
P2860
Decreased intracellular zinc in human tumorigenic prostate epithelial cells: a possible role in prostate cancer progression
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Decreased intracellular zinc i ...... in prostate cancer progression
@ast
Decreased intracellular zinc i ...... in prostate cancer progression
@en
Decreased intracellular zinc i ...... in prostate cancer progression
@nl
type
label
Decreased intracellular zinc i ...... in prostate cancer progression
@ast
Decreased intracellular zinc i ...... in prostate cancer progression
@en
Decreased intracellular zinc i ...... in prostate cancer progression
@nl
prefLabel
Decreased intracellular zinc i ...... in prostate cancer progression
@ast
Decreased intracellular zinc i ...... in prostate cancer progression
@en
Decreased intracellular zinc i ...... in prostate cancer progression
@nl
P2093
P2860
P356
P1476
Decreased intracellular zinc i ...... in prostate cancer progression
@en
P2093
Catherine P Kirschke
Liping Huang
Yunfan Zhang
P2860
P2888
P356
10.1186/1475-2867-6-10
P577
2006-03-31T00:00:00Z
P5875
P6179
1053271539